Biography and Research Information
OverviewAI-generated summary
Farah Mazahvreh's research focuses on the duration of immune checkpoint inhibitors (ICI) in oncology. Her work investigates whether longer treatment durations are always more beneficial for cancer patients. Mazahvreh has co-authored publications with researchers Liyan Mazahreh, Ahmad Mazin M. Safar, and Samuel L. Schach from the University of Arkansas for Medical Sciences, with whom she shares one publication each. Her most recent publication is from 2025, and she is noted as recently active in her field.
Metrics
- Publications: 1
Selected Publications
-
Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better (2025)
Collaboration Network
Top Collaborators
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
- Abstract 3214: The duration of immune checkpoint inhibitors (ICI) in oncology: Longer is not better
Similar Researchers
Based on overlapping research topics